BRPI0712064B8 - derivados de (2r)-2-fenilpropanamida, uso e processo para preparação dos mesmos e composições farmacêuticas - Google Patents

derivados de (2r)-2-fenilpropanamida, uso e processo para preparação dos mesmos e composições farmacêuticas

Info

Publication number
BRPI0712064B8
BRPI0712064B8 BRPI0712064A BRPI0712064A BRPI0712064B8 BR PI0712064 B8 BRPI0712064 B8 BR PI0712064B8 BR PI0712064 A BRPI0712064 A BR PI0712064A BR PI0712064 A BRPI0712064 A BR PI0712064A BR PI0712064 B8 BRPI0712064 B8 BR PI0712064B8
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
preparation
useful
treatment
phenylpropanamide
Prior art date
Application number
BRPI0712064A
Other languages
English (en)
Inventor
Moriconi Alessio
Aramini Andrea
Bizzarri Cinzia
Allegretti Marcello
Candida Cesta Maria
Bertini Riccardo
Original Assignee
Dompe Spa
Dompe Farm Spa
Dompe Pha R Ma Spa Res & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa, Dompe Farm Spa, Dompe Pha R Ma Spa Res & Mfg filed Critical Dompe Spa
Publication of BRPI0712064A2 publication Critical patent/BRPI0712064A2/pt
Publication of BRPI0712064B1 publication Critical patent/BRPI0712064B1/pt
Publication of BRPI0712064B8 publication Critical patent/BRPI0712064B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/09—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by at least two halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/14—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

derivados de (2r)-2-fenilpropanamida, uso e processo para preparação dos mesmos e composições farmacêuticas. a presente invenção refere-se a novas (2r)-2-fenilpropanamidas que transportam um substituinte 4-sulfonilamino na posição 4 do grupo fenila e a composições farmacêuticas que as contêm, que são usadas como inibidores da quimiotaxia de células polimorfonucleadas e mononucleadas, e que são úteis no tratamento de vários distúrbios mediados pela quimiocina el-r+cxc. em particular, os compostos da invenção são úteis no tratamento e controle de patologias específicas dependentes de cxcr2 tais como bos, copd, angiogênese e melanoma.
BRPI0712064A 2006-05-18 2007-05-17 derivados de (2r)-2-fenilpropanamida, uso e processo para preparação dos mesmos e composições farmacêuticas BRPI0712064B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06114185.9 2006-05-18
EP06114185 2006-05-18
PCT/EP2007/054806 WO2007135080A2 (en) 2006-05-18 2007-05-17 (2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
BRPI0712064A2 BRPI0712064A2 (pt) 2011-12-20
BRPI0712064B1 BRPI0712064B1 (pt) 2020-10-20
BRPI0712064B8 true BRPI0712064B8 (pt) 2021-05-25

Family

ID=38353147

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0712064A BRPI0712064B8 (pt) 2006-05-18 2007-05-17 derivados de (2r)-2-fenilpropanamida, uso e processo para preparação dos mesmos e composições farmacêuticas

Country Status (23)

Country Link
US (2) US7652169B2 (pt)
EP (1) EP2024329B1 (pt)
JP (1) JP5161873B2 (pt)
KR (1) KR101422299B1 (pt)
CN (1) CN101448784B (pt)
AU (1) AU2007253424B2 (pt)
BR (1) BRPI0712064B8 (pt)
CA (1) CA2649794C (pt)
CY (1) CY1114532T1 (pt)
DK (1) DK2024329T3 (pt)
ES (1) ES2433095T3 (pt)
HK (1) HK1131380A1 (pt)
HR (1) HRP20130989T1 (pt)
IL (1) IL194939A (pt)
MX (1) MX2008013957A (pt)
NZ (1) NZ572075A (pt)
PL (1) PL2024329T3 (pt)
PT (1) PT2024329E (pt)
RS (1) RS53007B (pt)
RU (1) RU2457201C2 (pt)
SI (1) SI2024329T1 (pt)
WO (1) WO2007135080A2 (pt)
ZA (1) ZA200808907B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2166006A1 (en) * 2008-09-18 2010-03-24 Dompe' S.P.A. 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
KR101298651B1 (ko) * 2011-03-16 2013-08-21 연세대학교 산학협력단 효능이 강화된 혈관신생 억제용 약제학적 조성물
CN103159674A (zh) * 2013-04-03 2013-06-19 苏州安诺生物医药技术有限公司 2-苯烷酰胺类化合物及其制备方法、药物组合物和用途
US10301378B2 (en) 2013-06-18 2019-05-28 New York University Cellular factors involved in the cytotoxicity of Staphylococcus aureus leukocidins: novel therapeutic targets
EP3174851A1 (en) * 2014-07-31 2017-06-07 GlaxoSmithKline Intellectual Property Management Limited Use of cxcr2 antagonists for the prevention and/or treatment of chemotherapy induced peripheral neuropathy (cipn)
EP3884932A1 (en) 2020-03-26 2021-09-29 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19
IL296751A (en) 2020-03-26 2022-11-01 Dompe Farm Spa cxcl8 inhibitors for use in the treatment of covid-19
EP4008325A1 (en) 2020-12-02 2022-06-08 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN188162B (pt) * 1999-02-05 2002-08-31 Torrent Pharmaceuticals Ltd
IT1317826B1 (it) 2000-02-11 2003-07-15 Dompe Spa Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8.
ITMI20012434A1 (it) * 2001-11-20 2003-05-20 Dompe Spa Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono
EP1457485A1 (en) * 2003-03-14 2004-09-15 Dompé S.P.A. Sulfonic acids, their derivatives and pharmaceutical compositions containing them
KR100707123B1 (ko) * 2003-07-02 2007-04-16 그뤼넨탈 게엠베하 바닐로이드 수용체의 길항제로서 강력한 진통효과를나타내는 4-(메틸설포닐아미노)페닐 동족체 및 이를함유하는 약학적 조성물
EP1776336B1 (en) * 2004-03-23 2009-09-30 DOMPE' pha.r.ma s.p.a. 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
MX2007007133A (es) * 2004-12-15 2007-08-08 Dompe Pha R Ma Spa Res & Mfg Derivados de acido 2-arilpropionico y composiciones farmaceuticas que los contienen.

Also Published As

Publication number Publication date
WO2007135080A2 (en) 2007-11-29
NZ572075A (en) 2011-11-25
AU2007253424A1 (en) 2007-11-29
CA2649794C (en) 2016-02-16
CA2649794A1 (en) 2007-11-29
IL194939A (en) 2015-02-26
US7652169B2 (en) 2010-01-26
JP5161873B2 (ja) 2013-03-13
HRP20130989T1 (hr) 2013-12-06
PL2024329T3 (pl) 2014-03-31
MX2008013957A (es) 2008-11-14
RS53007B (en) 2014-04-30
SI2024329T1 (sl) 2014-01-31
CN101448784B (zh) 2012-07-04
RU2457201C2 (ru) 2012-07-27
KR20090010979A (ko) 2009-01-30
BRPI0712064A2 (pt) 2011-12-20
WO2007135080A3 (en) 2008-01-10
BRPI0712064B1 (pt) 2020-10-20
RU2008149936A (ru) 2010-06-27
EP2024329A2 (en) 2009-02-18
KR101422299B1 (ko) 2014-07-22
ZA200808907B (en) 2010-03-31
PT2024329E (pt) 2013-11-04
AU2007253424B2 (en) 2013-03-07
CY1114532T1 (el) 2016-10-05
HK1131380A1 (en) 2010-01-22
US20100152256A1 (en) 2010-06-17
IL194939A0 (en) 2009-08-03
ES2433095T3 (es) 2013-12-09
US7868046B2 (en) 2011-01-11
US20090093530A1 (en) 2009-04-09
JP2010505742A (ja) 2010-02-25
CN101448784A (zh) 2009-06-03
DK2024329T3 (da) 2013-11-04
EP2024329B1 (en) 2013-07-31

Similar Documents

Publication Publication Date Title
BRPI0712064B8 (pt) derivados de (2r)-2-fenilpropanamida, uso e processo para preparação dos mesmos e composições farmacêuticas
BRPI0609719B8 (pt) derivados de acetilenil-pirazol-pirimidina como antagonistas de mgbur2
SE0301010D0 (sv) Novel compounds
BRPI0508724A (pt) derivados do fenilaminoetanol como agonistas do receptor beta2
SE0301009D0 (sv) Novel compounds
BRPI0510453A (pt) composto substituìdos com morfolina para o tratamento de distúrbios do sistema nervoso central
BRPI0510664A (pt) derivados de fenol e tiofenol 3 ou 4-monosubstituìdo úteis como ligantes de h3
BRPI0606964A2 (pt) pirrolidinas e piperidinas derivadas do acetileno para uso como antagonistas de mglur5
BRPI0509369A (pt) azaindóis úteis como inibidores de jak e outras proteìna cinases
BRPI0709633B8 (pt) derivados de piridina e pirimidina como antagonistas de mglur2, composição farmacêutica e uso dos mesmos
BRPI0507041A (pt) composto derivados de sulfonamida para o tratamento de doenças seus usos, processo para a preparação dos compostos e combinação de compostos
BRPI0717970C1 (pt) composto inibidor de 11betahsd1, composição farmacêutica, e, uso do composto
BRPI0507481A (pt) composto, composição farmacêutica, uso do composto, e, métodos para tratar distúrbios mediados por mglur 5 e para inibir ativação de receptores de mglur 5
BRPI0314325B8 (pt) derivados de aza-bicicloalquila, seu uso, seu processo de preparação e composição farmacêutica que os compreende
BRPI0415683A (pt) inibidores da reabsorção de norepinefrina para o tratamento de distúrbios do sistema nervoso central
NO20064160L (no) Nye azaibicykliske forbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
BRPI0515081A (pt) derivados de fenilaminopirimidina como inibidores de bcr-abl cinase
BRPI0507085A (pt) derivados de sulfonamida, composição farmacêutica, usos, processos para preparação e combinação
BRPI0508622B8 (pt) compostos de bifenil úteis como antagonistas do receptor muscarínico, composição farmacêutica, processo, medicamento e uso do composto.
HRP20050735B1 (hr) Dihidropteridinoni, metoda za njihovu proizvodnju i upotrebu u obliku lijekova
BRPI0507839A (pt) derivados tetraidroisoquinolinil de quinazolina e isoquinolina
BR0206433A (pt) Composto, composição farmacêutica, processo para a prepapação de um composto, e, uso de um composto
BRPI0713443A2 (pt) Derivados de piperazinila úteis no tratamento de doenças medianas por receptor gpr38, uso e composição farmacêutica contendo tais compostos e processos para preparação dos mesmos
NO20084712L (no) Nye farmasoytiske forbindelser
NO20085212L (no) Nye pyridinanaloger

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: DOMPE' S.P.A. (IT)

Free format text: TRANSFERIDO POR FUSAO DE: DOMPE PHA.R.MA S.P.A.

B25A Requested transfer of rights approved

Owner name: DOMPE FARMACEUTICI S.P.A (IT)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 20/10/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/05/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF